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StreptomycinAbstract Most bacteria causing ﬁsh diseases in Nigeria have been observed to be susceptible to
aminoglycosides like streptomycin. However, route of administration for effective therapy has been
a challenge due to the reported poor intestinal absorption, hence a need to study its kinetics.
Clarias gariepinus were divided into four groups of 14 ﬁsh each. Fish in A were Staphylococcus
aureus-infected while those in B were uninfected and both received streptomycin by bath at 70 mg/l,
while it was 70 mg/kg via gastric gavage for groups C which were Staphylococcus aureus-infected
and D which were uninfected. Blood and tissue collection was done between 1 and 120 h post expo-
sure to streptomycin. Samples were analyzed by ELISA, while some portions of tissues of infected
ﬁsh were ﬁxed for histopathology.
Sum of area under curve values for serum and kidney (AUC0–8h) were 5876.5 lg h/l and
399,287 lg h/kg; 4519.3 lg h/l and 183,474 lg h/kg; 27,771.2 lg h/l and 82,539 lg h/kg; as well as
18,768.4 lg h/l and 33,252.5 lg h/kg respectively for groups A, B, C and D. Microscopically the
lesions were localized and extensive hepatic coagulative necrosis with diffuse tubular necrosis.
Possible systemic therapeutic value is suggested, depending on increased distribution of strepto-
mycin and levels of streptomycin in kidneys of diseased ﬁsh at corresponding times being higher
than in sera.
ª 2014 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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In Nigeria, Clarias gariepinus (also known as African catﬁsh) is
predominantly cultured among ﬁsh farmers. Data from the
‘‘inventory of ﬁsh farms in Nigeria’’ published in December
2004 by AIFP (Aquaculture and Inland Fisheries Project),
showed that 1909 out of 2658 farms (71.8%) in Nigeria were
involved in production of Clarias gariepinus. Fish like other
animals are susceptible to bacterial infections. Ikpi and
Offem (2010) reported that bacterial infection among cultured
mudﬁsh Clarias gariepinus in Africa, has become a cause of
concern, because it constitutes the largest economic loss in ﬁsh
farms. Similarly at Mississippi state University it was reported
that of the overall catﬁsh losses in the United States caused by
infectious diseases, approximately 60 percent were the result of
single or mixed bacterial infections, 30 percent resulted from
parasitic infestations, 9 percent from fungal infections, and 1
percent of viral aetiology (MSU, 2010).
In bacterial disease outbreaks economic losses are due to
high mortalities, weight loss among survivors and cost of med-
ication. For controlling bacterial diseases of ﬁsh, it is impera-
tive to identify and address the source of infection, and
administer antibiotics at the right dose. Gentamicin, strepto-
mycin, amikacin, and neomycin are common examples of
aminoglycoside antibiotics. Streptomycin is known to exert
bactericidal action on bacteria by inhibition of protein synthe-
sis (Brander et al., 1991) and is reported to be poorly absorbed
from the intestine after oral administration compared with
other routes of administration (Booth, 1998). This then sug-
gests that it has no therapeutic value in controlling systemic
bacterial infection when administered orally to ﬁsh via feed
medication. This may probably be in the view of very low
plasma levels observed after oral administration.
He et al. (2012) described the pharmacokinetic disposition
of streptomycin sulfate in (Japanese Eel Anguilla japonica)
after single oral and intramuscular administrations. They were
of the opinion that since plasma therapeutic level could not be
achieved with the single oral dosing, only use of intramuscular
route could give a good result. Data of the antibiotic suscepti-
bility proﬁle of most bacterial isolates from poultry and ﬁsh
cases handled at the Animal care laboratory between Septem-
ber 2008 and December 2010 indicated that they were highly
sensitive to streptomycin. A subset of this data was reported
by Olarinmoye et al. (2013) who observed that 80% of avian
pathogenic Escherichia coli (APEC) isolates were susceptible
to streptomycin between May and August 2009, while within
same period, levels of resistance to amoxicillin, chlorampheni-
col and tetracycline were 99.2%, 96.5% and 91.4%, respec-
tively. This then points to a need to investigate the kinetics
of streptomycin sulfate administered to Clarias gariepinus by
gastric gavage or bath, since intramuscular administration of
this drug to a very large number of sick ﬁsh can be stressful
to both ﬁsh and handlers where treatment lasts for 3–5 days.
Materials and methods
Validation of drug purity
The purity of used streptomycin sulfate (Septocin from
CSPC Zhongnuo Pharmaceutical Co. Ltd, China) brand was
determined, based on the principle of alkaline hydrolysis ofstreptomycin to yield maltol (2-methyl-3-hydroxy-c-pyrone)
as described by Garratt (2005). It was found to have 94.6%
purity.
Experimental set-up
Fifty-six catﬁshes (Clarias gariepinus) with mean weight of
266.2 ± 18.6 g and mean length of 34.75 ± 1.86 cm were used.
Clarias gariepinus were stocked in four cylindrical plastic tanks
labelled A, B, C, and D at 14 ﬁshes/tank in 60 litres of water.
Experimental infection, drug administration and sample
collection
Each ﬁsh in the group A was infected with 0.5 ml of suspension
of Staphylococcus aureus (1.3 · 109 cfu/ml) intraperitoneally
and 17 h later, they were exposed to a streptomycin concentra-
tion of 70 mg/L in a water bath for 8 h. Group B ﬁsh were un-
infected and were exposed to streptomycin bath at the same
concentration. The Group C ﬁsh were infected (as those of
the group A) and they received streptomycin solution once,
by gastric gavage with those of group D (un-infected) at
70 mg/kg body weight, by the use of plastic syringe of 9.5 cm
length and 0.5 cm internal diameter. Two ﬁsh were randomly
taken per tank for blood and tissue collection at 1, 4, 8, 24,
72, and 120 h after exposure to streptomycin. At 8 h after
exposure to the drug, there was complete water change in all
groups and this was repeated every 24 h until the end of the
experiment.
After collection of blood samples via the caudal vein (using
a 21 gauge needle), ﬁshes had their spines, transected and
allowed to bleed before harvesting the liver, kidney and skele-
tal muscles. Lesions observed in ﬁsh of infected groups A and
C were recorded. Portions of livers and kidneys of infected ﬁsh
were ﬁxed in 10% neutral buffered formalin prior to sectioning
and staining with haematoxylin and eosin (H&E) as described
by Akpavie (2014). An Assay for the extraction and quantiﬁ-
cation of streptomycin was done as described by kit manufac-
turer (r-biopharm, Germany).
Streptomycin assay in tissues of Clarias gariepinus
a) Preparation of samples
Muscle. Half (0.5) a gram of homogenized muscle was vigor-
ously mixed with 2 ml of PBS-Tween-buffer for 30 min. This
gave 1:5 dilution. Mixture was centrifuged for 10 min at
4000 g. One ml of supernatant was separated. A 1: 300
dilution of supernatant was made, i.e. 1.67 ll of superna-
tant + 498.3 ll of PBS-Tween-buffer. This gave a ﬁnal
dilution of 1:1500 for skeletal muscle. Fifty microliter (50 ll)
of this dilution was used per well in an assay.
Liver and kidney. Samples were prepared as above, to the level
of supernatant. This was followed by a 1:1000 dilution of the
new supernatant i.e. 0.5 ll of supernatant + 499.5 ll of
PBS-Tween buffer, was made. This gave a ﬁnal dilution of
1:5000 for liver and kidney samples. Fifty microliter (50 ll)
of this dilution was used per well in the assay.
Serum. A 1:250 dilution, i.e. 2 ll of serum + 498 ll of PBS-
Tween buffer was made and 50 ll of this dilution in the assay.
Plate 1 Localized and extensive hepatic coagulative necrosis
(thin arrows) and hemosiderosis (thick arrow) at 72 h post-
infection H & E. ·300.
Plate 2 Kidney with diffuse tubular necrosis and multiple foci of
severe hemosiderosis (arrows) at 72 h post-infection H&E, ·300.
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Fifty microliter (50 ll) of each standard solution or prepared
sample was introduced into the wells of the streptomycin assay
kit and to each of these, 50 ll of the diluted enzyme conjugate
was added. Dilution of enzyme conjugate was done at 1 part to
10 parts of PBS-Tween buffer. In addition to these, 50 ll of the
diluted streptomycin antibody solution (1:10) was added in
each well and mixed gently by shaking the plate manually.
Incubation for 1hr at room temperature followed. The con-
tents of the wells were later discarded and the wells were
washed 5 times with washing buffer. To each well, 100 ll of
the substrate/chromogen was added and mixed gently by shak-
ing the plate manually. Incubation of sample was done for
15 min at room temperature in the dark.
A 100 ll of stop solution was added to each well and mixed
gently before the measurement of optical density at 450 nm
using a Microtiter plate reader (ELx 800 model from BioTek
Instruments, U.S.A.). Recording the optical densities was done
and the values were extrapolated on the streptomycin standard
curve to obtain values of streptomycin concentration in diluted
extract of tissues and sera, after multiplication by dilution fac-
tor. Limit of detection of streptomycin by kit is 5 ppb and
recovery rate of streptomycin 97%, while the speciﬁcity for
streptomycin is 100% as indicated by manufacturer.
Determination of pharmacokinetic parameters
The elimination half-life (t1/2 b) values for streptomycin in
serum samples of different groups were determined from the
line of best ﬁt obtained from a semi-log plot of serum concen-
tration versus time, taking the point of elimination from zero
hour after drug withdrawal. The rate constant of elimination
b(h1) was derived from the formula: t½b= 0.693/b.
Area under curve (AUC) values were determined by trape-
zoidal method as described by Riviere (1999). AUC is a deter-
minant of the bioavailability of the drug.
Results
Water temperature and pH ranged from 26 C to 28 C and
6.8–7.2, respectively. At 17 h after administration of the Staph-
ylococcus aureus inoculum, lethargy and erythema of ventral
region were observed in group A and C ﬁshes, while group B
and D ﬁshes remained active. After collection of blood sam-
ples, gross internal lesions observed in group A and C ﬁsh were
suffusion of inner wall of abdominal muscles, renal, and sple-
nic congestion, branchial pallor, and necrotic patches on the
liver. Microscopically, liver had localized and extensive hepatic
coagulative necrosis with hemosiderosis and in the kidneys,
diffuse tubular necrosis and multiple foci of severe hemosider-
osis (Plates 1 and 2).
With a wavelength of 450 nm, standards of streptomycin
concentration: 0 lg/L, 0.5 lg/L,1.5 lg/L, 4.5 lg/L, 13.5 lg/L,
and 40.5 lg/L gave 1.772, 1.474, 1.296, 1.026, 0.618,
and 0.52, respectively as optical densities. Following adminis-
tration of streptomycin sulfate to different groups of Clarias
gariepinus, various levels of the drug were detected in sera
and tissues over a period of 8 h exposure for groups A, B,C
and D and over 112 h after the drug withdrawal. The
maximum serum concentrations of streptomycin (serum
Cmax) for groups A, B, C and D were 971.7 ± 104.9 lg/l,1083.5 ± 383 lg/l, 5028.6 ± 0.14 lg/l, and 3730.5 ± 340 lg/l
at 8, 1, 8 and 4 h respectively.
The liver and kidney Cmax were 35,200 ± 17,185 lg/kg
and 69,550 ± 36,740 lg/kg; 85,000 ± 25,813 lg/kg and
60,157 ± 26,409 lg/kg; 53,490 ± 5311 lg/kg and 27,161 ±
11,523 lg/kg; as well as 62,992 ± 14,437 lg/kg and 9492 ±
1581 lg/kg, respectively for groups A, B, C, and D. Serum
area under curve values (AUC0–8 h) were 5876.45 lg h/l,
4519.3 lg h/l, 27,771.2 lg h/l, and 18,768.4 lg h/l, respectively
in groups A,B,C and D. Serum streptomycin elimination half-
life (t1/2 b) and sum of area under curve values for serum and
kidney (AUC0–8 h) were 64 h; 5876.5 and 399,287 lg h/kg,
23.2 h; 4519.3 and 183,474 lg h/kg, 44.2 h; 27,771.2 and
82,539 lg h/kg; as well as 17.4 h; 18,768.4 and 33,252.5 lg h/kg,
respectively in groups A, B, C and D (Table 8).
Discussion
Streptomycin is an aminoglycoside and is known to exert bac-
tericidal action on bacteria by inhibition of protein synthesis
(Brander et al., 1991). It is reported to be poorly absorbed
Figure 1 Streptomycin concentration in sera and tissues of
Staphylococcus aureus-infected Clarias gariepinus that received
streptomycin by bath at 70 mg/L (group A).
Figure 2 Streptomycin concentration in sera and tissues of
uninfected Clarias gariepinus that received streptomycin by bath at
70 mg/L (group B).
Table 1 Streptomycin concentration in sera and tissues of Staphylococcus aureus-infected Clarias gariepinus that received
streptomycin by bath at 70 mg/L (group A).
Time (hour) Group A
Streptomycin concentration (lg/l or lg/kg)
Serum Liver Kidney Muscle
1 566.5 ± 202 24,580 ± 5,573.2 19,333 ± 9,488 4558.8 ± 1,648.4
4 800 ± 284.9 15,626 ± 742.6 69,550 ± 36,740 3180 ± 1,256.7
8 971.7 ± 104.9 23,660 ± 6,180.7 58,598 ± 1.41 1805.9 ± 47.66
24 948.8 ± 331.5 35,200 ± 17,185 33,478 ± 13,280 2107.5 ± 663
72 510.4 ± 225.6 27,800 ± 3,430 27,988 ± 3,563 4323 ± 1,833
120 200 ± 88.75 5090 ± 594.1 5300 ± 777.9 2854 ± 1,060.8
Table 2 Streptomycin concentration in sera and tissues of uninfected Clarias gariepinus that received streptomycin by bath at 70 mg/L
(group B).
Time (hour) Group B
Streptomycin concentration (lg/l or lg/kg)
Serum Liver Kidney Muscle
1 1083.5 ± 383 20,089 ± 10,899 12,680 ± 1,329.6 1159 ± 423.6
4 550 ± 180 33,090 ± 7,079 10,800 ± 4,915 1504 ± 527.6
8 213.6 ± 113.7 11,983 ± 4,093 60,157 ± 26,409 862 ± 218
24 301.4 ± 5.09 7,843 ± 2,198 28,059 ± 11,238 7434 ± 3,644.3
72 87.5 ± 57.92 85,000 ± 25,813 28,080 ± 3,303 1905 ± 816.8
120 332 ± 31.82 15,715 ± 795.6 5412 ± 546.7 1258 ± 359.3
328 O.O. Oladele et al.from the intestine after oral administration compared with
other routes of administration (Booth, 1998).
This assumption may probably be in view of the very low
plasma levels observed after oral administration, coupled with
the fact that only blood samples were probably analyzed by
previous workers for streptomycin levels without the tissues,
simultaneously. This observation prompted an investigation
into its kinetics when administered orally (gavage) and by bath
to infected and uninfected Clarias gariepinus. Branchial
absorption (via gills) appears to occur during bath administra-
tion of antibiotics (Fiona et al., 2010). This could have played
a major role in groups A and B Clarias gariepinus subjected to
bath administration of streptomycin since the gills are highly
vascularized organs (see Figs. 1 and 2).Antoni and Marzenna (2007) showed that the minimum
bactericidal concentration (MBC) of streptomycin against 12
genera of aquatic bacteria isolated from water of river and res-
ervoirs ranged between 3.2 and 100 mg/L (i.e. 3200–100,000 lg/
L). Going by the lower value in this range, only group C ﬁsh
were maintained over 3200 lg/L of streptomycin concentration
in serum at 1 h, 8 h, 24 h and 72 h after drug administration,
while in group D, it was only at 4 h after drug administration.
In groups A and B that were bath medicated, no ﬁsh sample
attained such serum concentration of streptomycin (Tables 1
and 2 and Figs. 1 and 2). It is however very important to note
that liver and kidney tissues of ﬁshes in all groups, maintained
several times this MBC over a period of 24 h after drug with-
drawal, while the serum levels were low at corresponding times.
Table 3 Streptomycin concentration in sera and tissues of Staphylococcus aureus-infected Clarias gariepinus that received
streptomycin by gastric gavage at 70 mg/kg body weight (group C).
Time (hour) Group C
Streptomycin concentration (lg/l or lg/kg)
Serum Liver Kidney Muscle
1 3432 ± 1,143 20,493 ± 2,300 7094 ± 1,426.4 7047 ± 2,442
4 3100 ± 813.3 40,394 ± 3,178 5402 ± 2,848 2185 ± 11.32
8 5028.6 ± 0.14 46,106 ± 553.7 24,722 ± 5,272 7312 ± 4,704
24 4123 ± 188.5 53,490 ± 5,311 27,161 ± 11,523 3303 ± 1,978
72 3521 ± 188 32,320 ± 3,762 7294 ± 1,521 1250.5 ± 1,67.9
120 2512 ± 35.4 32,494 ± 14,502 2046 ± 258.8 806 ± 485.1
Table 4 Streptomycin concentration in sera and tissues of uninfected Clarias gariepinus that received streptomycin by gastric gavage
at 70 mg/kg body weight (group D).
Time (hour) Group D
Streptomycin concentration (lg/l or lg/kg)
Serum Liver Kidney Muscle
1 1233.3 ± 247.5 3921 ± 22.6 3594 ± 994.3 838 ± 513.4
4 3730.5 ± 340 59,210 ± 17,303 2023 ± 903 637.7 ± 229.1
8 1622.5 ± 10.25 54,500 ± 32,178 9492 ± 1581 1,985 ± 899.6
24 477.5 ± 82.39 62,992 ± 14,437 2834 ± 298.4 328.5 ± 114.9
72 122 ± 27.8 4458 ± 1,973 1956 ± 214.3 188.7 ± 85.5
120 27.4 ± 11.09 11,341 ± 4,358 1785 ± 335.9 243 ± 12.02
Figure 3 Streptomycin concentration in sera and tissues of
Staphylococcus aureus-infected Clarias gariepinus that received
streptomycin by gastric gavage at 70 mg/kg body weight (group
C).
Figure 4 Streptomycin concentration in sera and tissues of
uninfected Clarias gariepinus that received streptomycin by gastric
gavage at 70 mg/kg body weight (group D).
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absorption of streptomycin from the intestinal tract, signiﬁcant
levels of the drug got to the liver and kidney tissues between 1
and 8 h from onset of treatment by oral route (Tables 3 and 4,
Figs. 3 and 4). For example, within this period, the level of
streptomycin in the liver of group C ﬁsh ranged between 6
and 50 times the level of streptomycin in the sera at the corre-
sponding times, while at the 8th hour post administration, con-
centration in the kidney was approximately 5 times the level in
serum. This phenomenon suggests that aminoglycosides exhi-
bit low plasma protein binding (Shen et al., 2008), hence they
are released more from plasma to the tissues.
The process of inﬂammation and tissue damage appears to
have a marked inﬂuence on the level of streptomycin in the
kidney. In groups A and C (infected ﬁsh groups), the valuesof area under curve (AUC0–8 h) for kidneys, which is a reﬂec-
tion of the extent of distribution, were higher than those of
uninfected groups B and D (Table 5). Also, the AUC0–8 h value
for the group A ﬁsh kidney is approximately 2.2 times that of
the uninfected control group B. Severe damage to the renal tis-
sue in the infected ﬁsh can result in accumulation of the drug,
therein (Arcangelo and Peterson, 2006). The sum of the
AUC0–8 h (area under curve) values for each group (tissues
and sera) shows clearly that infected groups A and C, had
higher values than their uninfected controls, B and D groups
(Tables 5 and 6). This suggests higher absorption and distribu-
tion under disease condition.
The area under curve (AUC) for serum/plasma is an indica-
tor of the extent to which the drug was absorbed into the
Table 5 Area under curve values for serum streptomycin
(lg h/L).
AUC(0–8 Hrs) in lg h/l
Group A Group B Group C Group D
Serum (lg h/l) 5876.45 4519.3 27,771.2 18,768.4
Table 6 Area under curve values (AUC(0–8 Hrs)) for tissue
streptomycin (lg h/kg).
Group A Group B Group C Group D
Liver (lg h/kg) 151,171 179,959 274,577 324,077
Kidney (lg h/kg) 399,287 183,474 82,539 33,252.5
Muscle (lg h/kg) 23,859.4 9306 36,365.5 7877.95
Total (lg h/kg) 574,317.4 372,739 393,481.5 365,207.85
Table 7 Tissue to serum AUC ratios for groups A,B,C and D.
Liver:serum Kidney:serum Muscle:serum
Group A 25.72:1 67.95:1 4.06:1
Group B 39.82:1 40.6:1 2.06:1
Group C 9.89:1 2.97:1 1.31:1
Group D 17.26:1 1.77:1 0.42:1
330 O.O. Oladele et al.blood, while area under curve for tissues like liver, muscle and
kidney are indicators of extent of drug distribution. The ratio
between the values i.e. tissue AUC: serum AUC is very impor-
tant in understanding the movement of the drug between the
central and the peripheral compartment. Values of tissue to
serum area under curve ratio for groups A, B, C and D are
shown in Table 7. These values were generally higher for liver
and kidney than skeletal muscles in each group. This phenom-
enon may be linked with the fact that the liver and kidneyTable 8 Summary of pharmacokinetic parameters for groups A, B
Group A (infected) Group B (un-in
Dosage and route of
Streptomycin administration
70 mg/L.
(Bath administration)
70 mg/L.
(Bath administra
Serum C max. (lg/l) 971.7 ± 104.9 1083.5 ± 383
Serum T max. (h) 8 1
Liver C max. (lg/kg) 35,200 ± 17,185 85,000 ± 25,813
Liver T max (h) 24 72
Serum streptomycin
elimination
half life (t1/2 b)
64 23.2
Rate constant of
elimination b (h1)
0.011 0.03
kidney C max (lg/kg) 69,550 ± 36,740 60,157 ± 26,409
Kidney T max. (h) 4 8
Serum AUC{0–8 h} (lg h/L) 5876.45 4519.3
Liver/serum AUC ratio 25.72 39.82
Kidney/serum AUC ratio 67.95 40.6
Muscle/serum AUC ratio 4.06 2.06
Sum of organ AUC
(Liver + Kidney +Muscle){0-8h}
(lg h/kg)
574,317.4 372,739which are reddish-brown are richly vascularized (Hiran and
Datta-Mushi, 1996) in comparison with the skeletal muscles.
Similar patterns were noticed in the kinetics of Ciproﬂoxacin
in Clarias gariepinus bath medicated at different concentra-
tions and in soft and hard water (Oladele et al., 2010,
2011a). It is important to note that the ﬁrst pass effect seems
to inﬂuence a higher level of streptomycin AUC in liver of
the un-infected group D, compared with the infected group
C (Table 6) and this can result in more levels of the drug in
other tissues of infected ﬁsh.
Across all groups, only the group C ﬁsh could maintain
over 3200 lg/l concentration of streptomycin in serum over
8 h. When compared with the group D Clarias gariepinus
which were the control, the comparatively higher level of strep-
tomycin in group C serum might be strongly inﬂuenced by bet-
ter absorption associated with enteritis. This phenomenon may
have been responsible for the observation made by Oladele
et al. (2011b) when severe mortality in Clarias gariepinus was
brought under control after a 10-day therapy with streptomy-
cin at a comparatively lower dosage of 20 mg/kg via medicated
feed.
Comparing the two used routes, it appears that the groups
that received streptomycin by bath (A and B), retained the
drug in the skeletal muscles, more than those that received
streptomycin by a single oral dose (C and D), even though
the infected groups (A and C) comparatively had higher levels
than their respective uninfected control groups (B and D). This
may indicate a need for longer withdrawal periods when treat-
ing infected ﬁsh as against prophylactic use of streptomycin.
From the public health point of view, the E.U. regulation
stipulates that the maximum residue limit (MRL) for strepto-
mycin in skeletal muscle should be 500 lg/kg (EMEA, 2000).
Going by this regulation, only muscles of ﬁsh samples in the
group D will be ﬁt for human consumption from 16 h (24–
8 h) after drug withdrawal. This is not so for other groups.
For example in group C, with derived skeletal muscle elimina-
tion half-life of 49.6 h from the point of drug withdrawal, C and D.
fected) Group C (Infected) Group D (un-infected)
tion)
70 mg/kg body weight.
(By single oral administration)
70 mg/kg body weight
(By single oral administration)
5028.6 ± 0.14 3730.5 ± 340
8 4
53,490 ± 5311 62,992 ± 14,437
24 24
44.2 17.4
0.016 0.04
27,161 ± 11,523 9,492 ± 1581
24 8
27,771.2 18,768.4
9.89 17.26
2.97 1.77
1.31 0.42
393,481.5 365,207.85
Pharmacokinetics of streptomycin sulfate in Clarias gariepinus 331(water change), the streptomycin 7,312 lg/kg concentration in
muscle will drop to half its value under the tropical condi-
tion(27–28 C). To get to the 500 lg/kg level, there would be
a minimum of 3 half-lives, hence 49.6 · 3 h, i.e. 148.8 h or
6.2 days. Since ﬁsh is poikilothermic in nature, physiological
processes (like rate of drug elimination) will be strongly inﬂu-
enced by the water temperature (Ruth, 1998) and drug with-
drawal periods are measured in degree-days (Fiona et al.,
2010). The 6.2 days · average temperature of 27.5 C will give
170.5 days (degree-days) withdrawal period. This could take
longer period in the temperate regions of the world where much
lower temperatures prevail. Where the water temperature is
18 C, the 170.5 days withdrawal period will be equivalent to
9.4 days after 3 cycles of half-life of the drug in the muscle.
Knowledge of the kinetics of drugs in edible tissue is impor-
tant also because of the economic signiﬁcance. Exported ﬁsh
with high residues of antibiotics are rejected in countries with
very strong regulations. This is certainly a colossal loss to the
producers/exporters.
Considering the fact that aquaculture in Nigeria has been
expanding at high levels (FDF, 2007) and observations made
on the kinetics of streptomycin indicating signiﬁcant tissue lev-
els after oral administration, it is suggested that when treating
a large population of sick ﬁsh infected by bacteria that are sus-
ceptible to streptomycin, it will be much cheaper to administer
this drug via feed as it is practically impossible to inject thou-
sands of ﬁsh, daily for 3–5 days treatment. There is however a
need to exercise caution as sufﬁcient time must be given after
treatment to ensure reduction in tissue levels of the drug.
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